Cryo-Cell International Q3 2024 GAAP EPS $0.13 Beats $0.02 Estimate, Sales $8.07M Beat $7.98M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cryo-Cell International reported Q3 2024 earnings per share of $0.13, significantly surpassing the analyst estimate of $0.02. Sales also exceeded expectations, reaching $8.07 million. Both earnings and sales showed growth compared to the previous year.
October 15, 2024 | 9:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cryo-Cell International's Q3 2024 earnings per share of $0.13 beat the analyst estimate of $0.02 by 550%, and sales of $8.07M exceeded the $7.98M estimate. Both metrics showed growth from the previous year.
The significant beat on both EPS and sales estimates, along with year-over-year growth, is likely to positively impact Cryo-Cell International's stock price in the short term. The 550% EPS beat is particularly noteworthy and suggests strong operational performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100